tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TAK Stock Latest News

Takeda’s FRUZAQLA reimbursed in Quebec for treatment of mCRC
The FlyTakeda’s FRUZAQLA reimbursed in Quebec for treatment of mCRC
12h ago
TAK
Ionis Pharmaceuticals price target raised to $70 from $65 at H.C. Wainwright
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $70 from $65 at H.C. Wainwright
7d ago
TAK
IONS
Takeda Pharmaceutical Reports Q1 2025 Earnings
PremiumCompany Announcements
Takeda Pharmaceutical Reports Q1 2025 Earnings
29d ago
TAK
Takeda reports Q1 core EPS 151 yen vs. 176 yen last year
PremiumThe Fly
Takeda reports Q1 core EPS 151 yen vs. 176 yen last year
30d ago
TAK
Takeda backs FY25 core EPS view 485 yen
PremiumThe Fly
Takeda backs FY25 core EPS view 485 yen
30d ago
TAK
Alkermes selling off on limited data disclosure, says BofA
PremiumThe FlyAlkermes selling off on limited data disclosure, says BofA
1M ago
TAK
ALKS
Takeda receives FDA clearance for HyHub, HyHub Duo
Premium
The Fly
Takeda receives FDA clearance for HyHub, HyHub Duo
1M ago
TAK
Avidity, Phathom mentioned as potential takeout targets at Needham
Premium
The Fly
Avidity, Phathom mentioned as potential takeout targets at Needham
1M ago
BMY
NVO
Keros Therapeutics announces first patient dosed in Phase 3 RENEW trial
PremiumThe Fly
Keros Therapeutics announces first patient dosed in Phase 3 RENEW trial
1M ago
TAK
KROS
Buy Rating for Takeda Pharmaceutical Driven by Successful Phase 3 Trials of Oveporexton
PremiumRatings
Buy Rating for Takeda Pharmaceutical Driven by Successful Phase 3 Trials of Oveporexton
1M ago
TAK
Morning Movers: Sonnet BioTherapeutics skyrockets after $888M combination
PremiumThe Fly
Morning Movers: Sonnet BioTherapeutics skyrockets after $888M combination
2M ago
AZN
TAK
Takeda announces oveporexton studies met all primary, secondary endpoints
PremiumThe Fly
Takeda announces oveporexton studies met all primary, secondary endpoints
2M ago
TAK
Takeda Pharmaceutical Releases Corporate Governance Report
PremiumCompany AnnouncementsTakeda Pharmaceutical Releases Corporate Governance Report
2M ago
6K
TAK
Takeda Pharmaceutical Issues $2.4 Billion in Guaranteed Notes
Premium
Company Announcements
Takeda Pharmaceutical Issues $2.4 Billion in Guaranteed Notes
2M ago
6K
TAK
Takeda Pharmaceutical’s 149th Shareholders Meeting Approves Key Resolutions
Premium
Company Announcements
Takeda Pharmaceutical’s 149th Shareholders Meeting Approves Key Resolutions
2M ago
6K
TAK
Takeda’s 2025 Report Highlights Strong Growth and Leadership Transition
PremiumCompany Announcements
Takeda’s 2025 Report Highlights Strong Growth and Leadership Transition
2M ago
6K
TAK
Takeda announces FDA approval of Gammagard Liquid ERC
PremiumThe Fly
Takeda announces FDA approval of Gammagard Liquid ERC
2M ago
TAK
Takeda Completes Share Repurchase Program in May 2025
PremiumCompany Announcements
Takeda Completes Share Repurchase Program in May 2025
3M ago
6K
TAK
Takeda Defends Leadership Amid Shareholder Voting Recommendations
PremiumCompany Announcements
Takeda Defends Leadership Amid Shareholder Voting Recommendations
3M ago
6K
TAK
Takeda reports EC approves Adcetris combination for Hodgkin lymphoma
PremiumThe FlyTakeda reports EC approves Adcetris combination for Hodgkin lymphoma
3M ago
TAK
Positive Outlook for Takeda Pharmaceutical Co: Buy Rating Supported by Promising Phase 3 Data and Projected Sales for Rusfertide
Premium
Ratings
Positive Outlook for Takeda Pharmaceutical Co: Buy Rating Supported by Promising Phase 3 Data and Projected Sales for Rusfertide
3M ago
TAK
Protagonist, Takeda announces Phase 3 VERIFY study met primary endpoint
Premium
The Fly
Protagonist, Takeda announces Phase 3 VERIFY study met primary endpoint
3M ago
TAK
PTGX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >